Global Mesalazine API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 121

Published Date: 14 Sep 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

According to our (Global Info Research) latest study, the global Mesalazine API market size was valued at US$ 185 million in 2023 and is forecast to a readjusted size of USD 236 million by 2030 with a CAGR of 3.6% during review period.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

This report is a detailed and comprehensive analysis for global Mesalazine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Mesalazine API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Mesalazine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Mesalazine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Mesalazine API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mesalazine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mesalazine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Mesalazine API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Above 97 %
    Above 98 %
    Above 99 %

Market segment by Application
    Tablets
    Capsules
    Granule
    Suppository
    Enema
    Others

Major players covered
    PharmaZell
    Syntese A/S
    Cambrex Corporation
    Divis Laboratories
    Chemi SpA
    Ipca Laboratories
    Hangzhou Brother
    Lianyungang Fengheng Biopharm
    Lasa Loboratory
    Corden Pharma Bergamo
    Erregierre SpA
    CTX Lifescience
    Ishita Active Pharma Ingredients
    YC Biotech (Jiangsu)
    Xinxiang Tianfeng Fine Chemical

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mesalazine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mesalazine API, with price, sales quantity, revenue, and global market share of Mesalazine API from 2019 to 2024.
Chapter 3, the Mesalazine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesalazine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Mesalazine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalazine API.
Chapter 14 and 15, to describe Mesalazine API sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Mesalazine API Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Above 97 %
        1.3.3 Above 98 %
        1.3.4 Above 99 %
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Mesalazine API Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Tablets
        1.4.3 Capsules
        1.4.4 Granule
        1.4.5 Suppository
        1.4.6 Enema
        1.4.7 Others
    1.5 Global Mesalazine API Market Size & Forecast
        1.5.1 Global Mesalazine API Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Mesalazine API Sales Quantity (2019-2030)
        1.5.3 Global Mesalazine API Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 PharmaZell
        2.1.1 PharmaZell Details
        2.1.2 PharmaZell Major Business
        2.1.3 PharmaZell Mesalazine API Product and Services
        2.1.4 PharmaZell Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 PharmaZell Recent Developments/Updates
    2.2 Syntese A/S
        2.2.1 Syntese A/S Details
        2.2.2 Syntese A/S Major Business
        2.2.3 Syntese A/S Mesalazine API Product and Services
        2.2.4 Syntese A/S Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Syntese A/S Recent Developments/Updates
    2.3 Cambrex Corporation
        2.3.1 Cambrex Corporation Details
        2.3.2 Cambrex Corporation Major Business
        2.3.3 Cambrex Corporation Mesalazine API Product and Services
        2.3.4 Cambrex Corporation Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Cambrex Corporation Recent Developments/Updates
    2.4 Divis Laboratories
        2.4.1 Divis Laboratories Details
        2.4.2 Divis Laboratories Major Business
        2.4.3 Divis Laboratories Mesalazine API Product and Services
        2.4.4 Divis Laboratories Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Divis Laboratories Recent Developments/Updates
    2.5 Chemi SpA
        2.5.1 Chemi SpA Details
        2.5.2 Chemi SpA Major Business
        2.5.3 Chemi SpA Mesalazine API Product and Services
        2.5.4 Chemi SpA Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Chemi SpA Recent Developments/Updates
    2.6 Ipca Laboratories
        2.6.1 Ipca Laboratories Details
        2.6.2 Ipca Laboratories Major Business
        2.6.3 Ipca Laboratories Mesalazine API Product and Services
        2.6.4 Ipca Laboratories Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Ipca Laboratories Recent Developments/Updates
    2.7 Hangzhou Brother
        2.7.1 Hangzhou Brother Details
        2.7.2 Hangzhou Brother Major Business
        2.7.3 Hangzhou Brother Mesalazine API Product and Services
        2.7.4 Hangzhou Brother Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Hangzhou Brother Recent Developments/Updates
    2.8 Lianyungang Fengheng Biopharm
        2.8.1 Lianyungang Fengheng Biopharm Details
        2.8.2 Lianyungang Fengheng Biopharm Major Business
        2.8.3 Lianyungang Fengheng Biopharm Mesalazine API Product and Services
        2.8.4 Lianyungang Fengheng Biopharm Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
    2.9 Lasa Loboratory
        2.9.1 Lasa Loboratory Details
        2.9.2 Lasa Loboratory Major Business
        2.9.3 Lasa Loboratory Mesalazine API Product and Services
        2.9.4 Lasa Loboratory Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Lasa Loboratory Recent Developments/Updates
    2.10 Corden Pharma Bergamo
        2.10.1 Corden Pharma Bergamo Details
        2.10.2 Corden Pharma Bergamo Major Business
        2.10.3 Corden Pharma Bergamo Mesalazine API Product and Services
        2.10.4 Corden Pharma Bergamo Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Corden Pharma Bergamo Recent Developments/Updates
    2.11 Erregierre SpA
        2.11.1 Erregierre SpA Details
        2.11.2 Erregierre SpA Major Business
        2.11.3 Erregierre SpA Mesalazine API Product and Services
        2.11.4 Erregierre SpA Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Erregierre SpA Recent Developments/Updates
    2.12 CTX Lifescience
        2.12.1 CTX Lifescience Details
        2.12.2 CTX Lifescience Major Business
        2.12.3 CTX Lifescience Mesalazine API Product and Services
        2.12.4 CTX Lifescience Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 CTX Lifescience Recent Developments/Updates
    2.13 Ishita Active Pharma Ingredients
        2.13.1 Ishita Active Pharma Ingredients Details
        2.13.2 Ishita Active Pharma Ingredients Major Business
        2.13.3 Ishita Active Pharma Ingredients Mesalazine API Product and Services
        2.13.4 Ishita Active Pharma Ingredients Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
    2.14 YC Biotech (Jiangsu)
        2.14.1 YC Biotech (Jiangsu) Details
        2.14.2 YC Biotech (Jiangsu) Major Business
        2.14.3 YC Biotech (Jiangsu) Mesalazine API Product and Services
        2.14.4 YC Biotech (Jiangsu) Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
    2.15 Xinxiang Tianfeng Fine Chemical
        2.15.1 Xinxiang Tianfeng Fine Chemical Details
        2.15.2 Xinxiang Tianfeng Fine Chemical Major Business
        2.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Product and Services
        2.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates

3 Competitive Environment: Mesalazine API by Manufacturer
    3.1 Global Mesalazine API Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Mesalazine API Revenue by Manufacturer (2019-2024)
    3.3 Global Mesalazine API Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Mesalazine API by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Mesalazine API Manufacturer Market Share in 2023
        3.4.3 Top 6 Mesalazine API Manufacturer Market Share in 2023
    3.5 Mesalazine API Market: Overall Company Footprint Analysis
        3.5.1 Mesalazine API Market: Region Footprint
        3.5.2 Mesalazine API Market: Company Product Type Footprint
        3.5.3 Mesalazine API Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Mesalazine API Market Size by Region
        4.1.1 Global Mesalazine API Sales Quantity by Region (2019-2030)
        4.1.2 Global Mesalazine API Consumption Value by Region (2019-2030)
        4.1.3 Global Mesalazine API Average Price by Region (2019-2030)
    4.2 North America Mesalazine API Consumption Value (2019-2030)
    4.3 Europe Mesalazine API Consumption Value (2019-2030)
    4.4 Asia-Pacific Mesalazine API Consumption Value (2019-2030)
    4.5 South America Mesalazine API Consumption Value (2019-2030)
    4.6 Middle East & Africa Mesalazine API Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Mesalazine API Sales Quantity by Type (2019-2030)
    5.2 Global Mesalazine API Consumption Value by Type (2019-2030)
    5.3 Global Mesalazine API Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Mesalazine API Sales Quantity by Application (2019-2030)
    6.2 Global Mesalazine API Consumption Value by Application (2019-2030)
    6.3 Global Mesalazine API Average Price by Application (2019-2030)

7 North America
    7.1 North America Mesalazine API Sales Quantity by Type (2019-2030)
    7.2 North America Mesalazine API Sales Quantity by Application (2019-2030)
    7.3 North America Mesalazine API Market Size by Country
        7.3.1 North America Mesalazine API Sales Quantity by Country (2019-2030)
        7.3.2 North America Mesalazine API Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Mesalazine API Sales Quantity by Type (2019-2030)
    8.2 Europe Mesalazine API Sales Quantity by Application (2019-2030)
    8.3 Europe Mesalazine API Market Size by Country
        8.3.1 Europe Mesalazine API Sales Quantity by Country (2019-2030)
        8.3.2 Europe Mesalazine API Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Mesalazine API Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Mesalazine API Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Mesalazine API Market Size by Region
        9.3.1 Asia-Pacific Mesalazine API Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Mesalazine API Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Mesalazine API Sales Quantity by Type (2019-2030)
    10.2 South America Mesalazine API Sales Quantity by Application (2019-2030)
    10.3 South America Mesalazine API Market Size by Country
        10.3.1 South America Mesalazine API Sales Quantity by Country (2019-2030)
        10.3.2 South America Mesalazine API Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Mesalazine API Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Mesalazine API Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Mesalazine API Market Size by Country
        11.3.1 Middle East & Africa Mesalazine API Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Mesalazine API Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Mesalazine API Market Drivers
    12.2 Mesalazine API Market Restraints
    12.3 Mesalazine API Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Mesalazine API and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Mesalazine API
    13.3 Mesalazine API Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Mesalazine API Typical Distributors
    14.3 Mesalazine API Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Mesalazine API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Mesalazine API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. PharmaZell Basic Information, Manufacturing Base and Competitors
 Table 4. PharmaZell Major Business
 Table 5. PharmaZell Mesalazine API Product and Services
 Table 6. PharmaZell Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. PharmaZell Recent Developments/Updates
 Table 8. Syntese A/S Basic Information, Manufacturing Base and Competitors
 Table 9. Syntese A/S Major Business
 Table 10. Syntese A/S Mesalazine API Product and Services
 Table 11. Syntese A/S Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Syntese A/S Recent Developments/Updates
 Table 13. Cambrex Corporation Basic Information, Manufacturing Base and Competitors
 Table 14. Cambrex Corporation Major Business
 Table 15. Cambrex Corporation Mesalazine API Product and Services
 Table 16. Cambrex Corporation Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Cambrex Corporation Recent Developments/Updates
 Table 18. Divis Laboratories Basic Information, Manufacturing Base and Competitors
 Table 19. Divis Laboratories Major Business
 Table 20. Divis Laboratories Mesalazine API Product and Services
 Table 21. Divis Laboratories Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Divis Laboratories Recent Developments/Updates
 Table 23. Chemi SpA Basic Information, Manufacturing Base and Competitors
 Table 24. Chemi SpA Major Business
 Table 25. Chemi SpA Mesalazine API Product and Services
 Table 26. Chemi SpA Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Chemi SpA Recent Developments/Updates
 Table 28. Ipca Laboratories Basic Information, Manufacturing Base and Competitors
 Table 29. Ipca Laboratories Major Business
 Table 30. Ipca Laboratories Mesalazine API Product and Services
 Table 31. Ipca Laboratories Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Ipca Laboratories Recent Developments/Updates
 Table 33. Hangzhou Brother Basic Information, Manufacturing Base and Competitors
 Table 34. Hangzhou Brother Major Business
 Table 35. Hangzhou Brother Mesalazine API Product and Services
 Table 36. Hangzhou Brother Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Hangzhou Brother Recent Developments/Updates
 Table 38. Lianyungang Fengheng Biopharm Basic Information, Manufacturing Base and Competitors
 Table 39. Lianyungang Fengheng Biopharm Major Business
 Table 40. Lianyungang Fengheng Biopharm Mesalazine API Product and Services
 Table 41. Lianyungang Fengheng Biopharm Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Lianyungang Fengheng Biopharm Recent Developments/Updates
 Table 43. Lasa Loboratory Basic Information, Manufacturing Base and Competitors
 Table 44. Lasa Loboratory Major Business
 Table 45. Lasa Loboratory Mesalazine API Product and Services
 Table 46. Lasa Loboratory Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Lasa Loboratory Recent Developments/Updates
 Table 48. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors
 Table 49. Corden Pharma Bergamo Major Business
 Table 50. Corden Pharma Bergamo Mesalazine API Product and Services
 Table 51. Corden Pharma Bergamo Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. Corden Pharma Bergamo Recent Developments/Updates
 Table 53. Erregierre SpA Basic Information, Manufacturing Base and Competitors
 Table 54. Erregierre SpA Major Business
 Table 55. Erregierre SpA Mesalazine API Product and Services
 Table 56. Erregierre SpA Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. Erregierre SpA Recent Developments/Updates
 Table 58. CTX Lifescience Basic Information, Manufacturing Base and Competitors
 Table 59. CTX Lifescience Major Business
 Table 60. CTX Lifescience Mesalazine API Product and Services
 Table 61. CTX Lifescience Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. CTX Lifescience Recent Developments/Updates
 Table 63. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors
 Table 64. Ishita Active Pharma Ingredients Major Business
 Table 65. Ishita Active Pharma Ingredients Mesalazine API Product and Services
 Table 66. Ishita Active Pharma Ingredients Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. Ishita Active Pharma Ingredients Recent Developments/Updates
 Table 68. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors
 Table 69. YC Biotech (Jiangsu) Major Business
 Table 70. YC Biotech (Jiangsu) Mesalazine API Product and Services
 Table 71. YC Biotech (Jiangsu) Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 72. YC Biotech (Jiangsu) Recent Developments/Updates
 Table 73. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors
 Table 74. Xinxiang Tianfeng Fine Chemical Major Business
 Table 75. Xinxiang Tianfeng Fine Chemical Mesalazine API Product and Services
 Table 76. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
 Table 78. Global Mesalazine API Sales Quantity by Manufacturer (2019-2024) & (Tons)
 Table 79. Global Mesalazine API Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 80. Global Mesalazine API Average Price by Manufacturer (2019-2024) & (US$/kg)
 Table 81. Market Position of Manufacturers in Mesalazine API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 82. Head Office and Mesalazine API Production Site of Key Manufacturer
 Table 83. Mesalazine API Market: Company Product Type Footprint
 Table 84. Mesalazine API Market: Company Product Application Footprint
 Table 85. Mesalazine API New Market Entrants and Barriers to Market Entry
 Table 86. Mesalazine API Mergers, Acquisition, Agreements, and Collaborations
 Table 87. Global Mesalazine API Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 88. Global Mesalazine API Sales Quantity by Region (2019-2024) & (Tons)
 Table 89. Global Mesalazine API Sales Quantity by Region (2025-2030) & (Tons)
 Table 90. Global Mesalazine API Consumption Value by Region (2019-2024) & (USD Million)
 Table 91. Global Mesalazine API Consumption Value by Region (2025-2030) & (USD Million)
 Table 92. Global Mesalazine API Average Price by Region (2019-2024) & (US$/kg)
 Table 93. Global Mesalazine API Average Price by Region (2025-2030) & (US$/kg)
 Table 94. Global Mesalazine API Sales Quantity by Type (2019-2024) & (Tons)
 Table 95. Global Mesalazine API Sales Quantity by Type (2025-2030) & (Tons)
 Table 96. Global Mesalazine API Consumption Value by Type (2019-2024) & (USD Million)
 Table 97. Global Mesalazine API Consumption Value by Type (2025-2030) & (USD Million)
 Table 98. Global Mesalazine API Average Price by Type (2019-2024) & (US$/kg)
 Table 99. Global Mesalazine API Average Price by Type (2025-2030) & (US$/kg)
 Table 100. Global Mesalazine API Sales Quantity by Application (2019-2024) & (Tons)
 Table 101. Global Mesalazine API Sales Quantity by Application (2025-2030) & (Tons)
 Table 102. Global Mesalazine API Consumption Value by Application (2019-2024) & (USD Million)
 Table 103. Global Mesalazine API Consumption Value by Application (2025-2030) & (USD Million)
 Table 104. Global Mesalazine API Average Price by Application (2019-2024) & (US$/kg)
 Table 105. Global Mesalazine API Average Price by Application (2025-2030) & (US$/kg)
 Table 106. North America Mesalazine API Sales Quantity by Type (2019-2024) & (Tons)
 Table 107. North America Mesalazine API Sales Quantity by Type (2025-2030) & (Tons)
 Table 108. North America Mesalazine API Sales Quantity by Application (2019-2024) & (Tons)
 Table 109. North America Mesalazine API Sales Quantity by Application (2025-2030) & (Tons)
 Table 110. North America Mesalazine API Sales Quantity by Country (2019-2024) & (Tons)
 Table 111. North America Mesalazine API Sales Quantity by Country (2025-2030) & (Tons)
 Table 112. North America Mesalazine API Consumption Value by Country (2019-2024) & (USD Million)
 Table 113. North America Mesalazine API Consumption Value by Country (2025-2030) & (USD Million)
 Table 114. Europe Mesalazine API Sales Quantity by Type (2019-2024) & (Tons)
 Table 115. Europe Mesalazine API Sales Quantity by Type (2025-2030) & (Tons)
 Table 116. Europe Mesalazine API Sales Quantity by Application (2019-2024) & (Tons)
 Table 117. Europe Mesalazine API Sales Quantity by Application (2025-2030) & (Tons)
 Table 118. Europe Mesalazine API Sales Quantity by Country (2019-2024) & (Tons)
 Table 119. Europe Mesalazine API Sales Quantity by Country (2025-2030) & (Tons)
 Table 120. Europe Mesalazine API Consumption Value by Country (2019-2024) & (USD Million)
 Table 121. Europe Mesalazine API Consumption Value by Country (2025-2030) & (USD Million)
 Table 122. Asia-Pacific Mesalazine API Sales Quantity by Type (2019-2024) & (Tons)
 Table 123. Asia-Pacific Mesalazine API Sales Quantity by Type (2025-2030) & (Tons)
 Table 124. Asia-Pacific Mesalazine API Sales Quantity by Application (2019-2024) & (Tons)
 Table 125. Asia-Pacific Mesalazine API Sales Quantity by Application (2025-2030) & (Tons)
 Table 126. Asia-Pacific Mesalazine API Sales Quantity by Region (2019-2024) & (Tons)
 Table 127. Asia-Pacific Mesalazine API Sales Quantity by Region (2025-2030) & (Tons)
 Table 128. Asia-Pacific Mesalazine API Consumption Value by Region (2019-2024) & (USD Million)
 Table 129. Asia-Pacific Mesalazine API Consumption Value by Region (2025-2030) & (USD Million)
 Table 130. South America Mesalazine API Sales Quantity by Type (2019-2024) & (Tons)
 Table 131. South America Mesalazine API Sales Quantity by Type (2025-2030) & (Tons)
 Table 132. South America Mesalazine API Sales Quantity by Application (2019-2024) & (Tons)
 Table 133. South America Mesalazine API Sales Quantity by Application (2025-2030) & (Tons)
 Table 134. South America Mesalazine API Sales Quantity by Country (2019-2024) & (Tons)
 Table 135. South America Mesalazine API Sales Quantity by Country (2025-2030) & (Tons)
 Table 136. South America Mesalazine API Consumption Value by Country (2019-2024) & (USD Million)
 Table 137. South America Mesalazine API Consumption Value by Country (2025-2030) & (USD Million)
 Table 138. Middle East & Africa Mesalazine API Sales Quantity by Type (2019-2024) & (Tons)
 Table 139. Middle East & Africa Mesalazine API Sales Quantity by Type (2025-2030) & (Tons)
 Table 140. Middle East & Africa Mesalazine API Sales Quantity by Application (2019-2024) & (Tons)
 Table 141. Middle East & Africa Mesalazine API Sales Quantity by Application (2025-2030) & (Tons)
 Table 142. Middle East & Africa Mesalazine API Sales Quantity by Country (2019-2024) & (Tons)
 Table 143. Middle East & Africa Mesalazine API Sales Quantity by Country (2025-2030) & (Tons)
 Table 144. Middle East & Africa Mesalazine API Consumption Value by Country (2019-2024) & (USD Million)
 Table 145. Middle East & Africa Mesalazine API Consumption Value by Country (2025-2030) & (USD Million)
 Table 146. Mesalazine API Raw Material
 Table 147. Key Manufacturers of Mesalazine API Raw Materials
 Table 148. Mesalazine API Typical Distributors
 Table 149. Mesalazine API Typical Customers


List of Figures
 Figure 1. Mesalazine API Picture
 Figure 2. Global Mesalazine API Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Mesalazine API Revenue Market Share by Type in 2023
 Figure 4. Above 97 % Examples
 Figure 5. Above 98 % Examples
 Figure 6. Above 99 % Examples
 Figure 7. Global Mesalazine API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Global Mesalazine API Revenue Market Share by Application in 2023
 Figure 9. Tablets Examples
 Figure 10. Capsules Examples
 Figure 11. Granule Examples
 Figure 12. Suppository Examples
 Figure 13. Enema Examples
 Figure 14. Others Examples
 Figure 15. Global Mesalazine API Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 16. Global Mesalazine API Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 17. Global Mesalazine API Sales Quantity (2019-2030) & (Tons)
 Figure 18. Global Mesalazine API Price (2019-2030) & (US$/kg)
 Figure 19. Global Mesalazine API Sales Quantity Market Share by Manufacturer in 2023
 Figure 20. Global Mesalazine API Revenue Market Share by Manufacturer in 2023
 Figure 21. Producer Shipments of Mesalazine API by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 22. Top 3 Mesalazine API Manufacturer (Revenue) Market Share in 2023
 Figure 23. Top 6 Mesalazine API Manufacturer (Revenue) Market Share in 2023
 Figure 24. Global Mesalazine API Sales Quantity Market Share by Region (2019-2030)
 Figure 25. Global Mesalazine API Consumption Value Market Share by Region (2019-2030)
 Figure 26. North America Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 27. Europe Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 28. Asia-Pacific Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 29. South America Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 30. Middle East & Africa Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 31. Global Mesalazine API Sales Quantity Market Share by Type (2019-2030)
 Figure 32. Global Mesalazine API Consumption Value Market Share by Type (2019-2030)
 Figure 33. Global Mesalazine API Average Price by Type (2019-2030) & (US$/kg)
 Figure 34. Global Mesalazine API Sales Quantity Market Share by Application (2019-2030)
 Figure 35. Global Mesalazine API Revenue Market Share by Application (2019-2030)
 Figure 36. Global Mesalazine API Average Price by Application (2019-2030) & (US$/kg)
 Figure 37. North America Mesalazine API Sales Quantity Market Share by Type (2019-2030)
 Figure 38. North America Mesalazine API Sales Quantity Market Share by Application (2019-2030)
 Figure 39. North America Mesalazine API Sales Quantity Market Share by Country (2019-2030)
 Figure 40. North America Mesalazine API Consumption Value Market Share by Country (2019-2030)
 Figure 41. United States Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 42. Canada Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 43. Mexico Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 44. Europe Mesalazine API Sales Quantity Market Share by Type (2019-2030)
 Figure 45. Europe Mesalazine API Sales Quantity Market Share by Application (2019-2030)
 Figure 46. Europe Mesalazine API Sales Quantity Market Share by Country (2019-2030)
 Figure 47. Europe Mesalazine API Consumption Value Market Share by Country (2019-2030)
 Figure 48. Germany Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 49. France Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 50. United Kingdom Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 51. Russia Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 52. Italy Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 53. Asia-Pacific Mesalazine API Sales Quantity Market Share by Type (2019-2030)
 Figure 54. Asia-Pacific Mesalazine API Sales Quantity Market Share by Application (2019-2030)
 Figure 55. Asia-Pacific Mesalazine API Sales Quantity Market Share by Region (2019-2030)
 Figure 56. Asia-Pacific Mesalazine API Consumption Value Market Share by Region (2019-2030)
 Figure 57. China Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 58. Japan Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 59. South Korea Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 60. India Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 61. Southeast Asia Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 62. Australia Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 63. South America Mesalazine API Sales Quantity Market Share by Type (2019-2030)
 Figure 64. South America Mesalazine API Sales Quantity Market Share by Application (2019-2030)
 Figure 65. South America Mesalazine API Sales Quantity Market Share by Country (2019-2030)
 Figure 66. South America Mesalazine API Consumption Value Market Share by Country (2019-2030)
 Figure 67. Brazil Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 68. Argentina Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 69. Middle East & Africa Mesalazine API Sales Quantity Market Share by Type (2019-2030)
 Figure 70. Middle East & Africa Mesalazine API Sales Quantity Market Share by Application (2019-2030)
 Figure 71. Middle East & Africa Mesalazine API Sales Quantity Market Share by Country (2019-2030)
 Figure 72. Middle East & Africa Mesalazine API Consumption Value Market Share by Country (2019-2030)
 Figure 73. Turkey Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 74. Egypt Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 75. Saudi Arabia Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 76. South Africa Mesalazine API Consumption Value (2019-2030) & (USD Million)
 Figure 77. Mesalazine API Market Drivers
 Figure 78. Mesalazine API Market Restraints
 Figure 79. Mesalazine API Market Trends
 Figure 80. Porters Five Forces Analysis
 Figure 81. Manufacturing Cost Structure Analysis of Mesalazine API in 2023
 Figure 82. Manufacturing Process Analysis of Mesalazine API
 Figure 83. Mesalazine API Industrial Chain
 Figure 84. Sales Channel: Direct to End-User vs Distributors
 Figure 85. Direct Channel Pros & Cons
 Figure 86. Indirect Channel Pros & Cons
 Figure 87. Methodology
 Figure 88. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Related Reports

Global Mesalazine API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Mesalazine API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 03 Jan 2023

date Chemical & Material

According to our (Global Info Research) latest study, the global Mesalazine API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Mesalazine API Supply, Demand and Key Producers, 2024-2030

Global Mesalazine API Supply, Demand and Key Producers, 2024-2030

date 14 Sep 2024

date Chemical & Material

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>